statistiche ricercatore

Continente	#
EU - Europa	664
AS - Asia	577
NA - Nord America	416
SA - Sud America	50
AF - Africa	19
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.729

Nazione	#
US - Stati Uniti d'America	390
DE - Germania	353
SG - Singapore	162
CN - Cina	152
IT - Italia	111
IN - India	75
BD - Bangladesh	39
BR - Brasile	37
HK - Hong Kong	37
VN - Vietnam	33
ES - Italia	31
SE - Svezia	31
GB - Regno Unito	27
JP - Giappone	27
RU - Federazione Russa	26
FR - Francia	22
CA - Canada	21
ID - Indonesia	15
CI - Costa d'Avorio	14
IE - Irlanda	14
KR - Corea	12
FI - Finlandia	11
NL - Olanda	10
AR - Argentina	7
NO - Norvegia	7
IQ - Iraq	5
PT - Portogallo	4
RO - Romania	4
TW - Taiwan	4
CH - Svizzera	3
JO - Giordania	3
KG - Kirghizistan	2
PH - Filippine	2
TR - Turchia	2
ZA - Sudafrica	2
AT - Austria	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BE - Belgio	1
BG - Bulgaria	1
BO - Bolivia	1
BW - Botswana	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
HN - Honduras	1
HU - Ungheria	1
IL - Israele	1
IS - Islanda	1
KE - Kenya	1
KW - Kuwait	1
KZ - Kazakistan	1
MA - Marocco	1
MX - Messico	1
MY - Malesia	1
NZ - Nuova Zelanda	1
OM - Oman	1
PE - Perù	1
PL - Polonia	1
PY - Paraguay	1
SI - Slovenia	1
SV - El Salvador	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.729

Nome	#
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer	414
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial	273
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors	266
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series	234
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial	233
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer	215
Breakthrough cancer pain clinical features and differential opioids response: A machine learning approach in patients with cancer from the IOPS-MS study	109
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO	18
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial	1
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial	1
Totale	1.764

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	8	0	0	0	0	0	0	0	0	0	0	0	8
2021/2022	105	5	5	5	6	4	6	7	17	19	11	7	13
2022/2023	168	18	18	9	14	14	32	8	11	18	5	17	4
2023/2024	391	15	11	29	25	24	17	51	42	22	46	60	49
2024/2025	421	46	43	44	55	29	22	32	25	19	29	34	43
2025/2026	648	54	34	57	57	77	31	80	17	48	54	124	15
Totale													1.764

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca